Citius Pharmaceuticals Reports Topline Data from the Pivotal Phase 3 Study of Cancer Immunotherapy.

Citius Pharmaceuticals Reports Topline Data from the Pivotal Phase 3 Study of Cancer Immunotherapy I/ONTAK (E7777) for the Treatment of Persistent or Recurrent Cutaneous...

Dalrada (DFCO). Our 11th and Latest Ten Bagger.

We've actually had many more than 11 ten-baggers, as we report on companies which aren't clients. This is our 11th client we should say,...
Biotech Stock Review

Citius Pharma (CTXR) Flexes Muscle in Business Update. Remains Our Top Idea.

Added to Watch List November 2019 @$0.55. Named Our Top Idea in 2020 @$1.02.Remains Our Top Idea in 2021 @$1.80Cash has Risen From $3.3 Million...

The FDA Cracks Down On Stem Cell Therapy.

Due to a somewhat unexpected crackdown on stem cell treatment centers a couple of weeks ago - we have decided to hold off launching...
Issam Radd

Citius (CTXR): Halt For Superiority On The Horizon? (SeekingAlpha).

Jun. 15, 2021 10:41 AM ET Citius Pharmaceuticals, Inc. (CTXR) Summary IDMC meets on June 29 for Superiority review.Mino-Lok has no competition.Price target increased to...
Biotech Stock Review. Citius, CTXR

More Great News From Citius Pharma (CTXR).

UPDATED CHART 6-15-21 Mino-Lok® Phase III, FDA NewsRussell 2000 Index NewsTechnical Breakout News We're up 370% since adding it to the Biotech Stock Review Watch List...
Internet Stock Review

Stocks On The Move!

Citius (CTXR) up 19%, Draganfly (DFLYF) up 31%, urban-gro (UGRO) up 37%, Provention (PVRB) flip-flopping, Hapbee Technologies (HAPBF) up 26% and the Alkaline Water...
Dalarada, Internet Stock Review

Discontinuing Coverage on Dalrada (DFCO).

We Are Temporarily Discontinuing Coverage on Dalrada Financial. Great little company and we're up 400%. But with the market for small caps getting a bit...

Citius Pharma (CTXR) Updates Shareholders.

Citius Update Stem Cell Study Citius Pharmaceuticals, Inc announced that it will present a poster at the International Society for Cell and Gene Therapy (ISCT)...
Stem Cell Stock Review

Old News, But Wow: Starr Foundation Reaffirms Support for Stem Cell Research with $50...

Someone is a Big Believer and Cutting Equally Big Checks! NEW YORK (April 4, 2019) — The Starr Foundation is continuing its longstanding commitment to...

Latest article

National Investment Bankers Conference

Companies Scheduled to Present Since 1982, The National Investment Banking Association (NIBA) has been serving the micro-cap and small-cap investment community. They have hosted 150...

Report: Sekur Private Data (SWISF) Awarded Place on GSA Schedule.

This Week's GSA Announcement Marks Sekur’s 4th Major Milestone. GSA Approval is akin to an electrician just starting out in the business, and being told...

Halted Stocks Watch List

We are following Companies which have been suspended by the SEC and will update news related to them here. In near real time. To...